Drug Side Effects A-Z: A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

report side effect Post Side Effect ask Ask Community compare side effects Compare Side Effects
Post Your Myleran Experience:

Recent Myleran Side Effect Reports

Myleran Side Effects Report #5285850-4
Consumer or non-health professional from UNITED STATES reported Myleran side effect on Mar 13, 2007. Female patient was diagnosed with aspiration bone marrow abnormal and was treated with Myleran. After drug was administered, patient experienced the following side effects: bone marrow failure, bone marrow transplant What is  bone marrow transplant, pancytopenia, trisomy 8. Myleran dosage: 37.5 MG/MIN/SEE TEXT/INTRAVENOUS. During the same period patient was treated with DAPSONE, PENTAMIDINE ISETHIONATE, CYANOCOBALAMIN, FOLIC ACID.




Myleran Side Effects Report #5363593-6
Myleran side effect was reported by a Consumer or non-health professional from FRANCE on June 12, 2007. Female patient, 47 years of age, weighting 121.3 lb, was treated with Myleran. After drug was administered, patient experienced the following side effects: atelectasis, dyspnoea, lung cyst benign, lung infiltration, obstructive airways disorder, pulmonary fibrosis What is  pulmonary fibrosis. Myleran dosage: 8MG PER DAY. During the same period patient was treated with ALKERAN, MELPHALAN. Patient was hospitalized.




ask View More ask View All Myleran FDA Adverse Reports
Myleran Side Effects
AplasiaAscitesAtelectasisComplications of bone marrow transplantConvulsionDyspnoeaEncephalopathyEngraftment syndromeFebrile neutropeniaGastrointestinal toxicityGraft versus host diseaseGraft versus host disease in skinHaemodialysisHepatic failureInfectionWhat is  InfectionInternational normalised ratio increasedLung cyst benignLung infiltrationMucosal inflammationMulti-organ failureNeurotoxicityNeutrophil count abnormalObstructive airways disorderPlatelet count decreasedPneumonitisPulmonary fibrosisWhat is  Pulmonary fibrosisPulmonary toxicityRespiratory failureSepsisWhat is  SepsisVenoocclusive diseaseVenoocclusive liver disease
Go to the top of the page

Myleran Questions

No comments have been provided.

Add Your Comment


Ask Community about Myleran:

What is Your Question? Ask Community:

Your Name:

Your Question:

Country (flag):

Your Location:

Security check *

security image
 


Myleran Adverse Effect Reports (FDA)
Quick-Add Your Side Effect:

Showing 1-50 of 51 Next >

Myleran Side Effects Report #5063371-1
Consumer or non-health professional from UNITED STATES reported Myleran side effect on Dec 27, 2005. Male patient, 73 years of age, was treated with Myleran. After drug was administered, patient experienced the following side effects: laboratory test abnormal. Myleran dosage: unknown.



Myleran Side Effects Report #5087223-6
Myleran side effect was reported by a Consumer or non-health professional from CANADA on Aug 03, 2006. Male patient, 54 years of age, was treated with Myleran. After drug was administered, patient experienced the following side effects: cerebral atrophy, oedema. Myleran dosage: 12.8 MG/KG INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, METHOTREXATE, CYCLOSPORINE.




Myleran Side Effects Report #5095334-4
Consumer or non-health professional from FRANCE reported Myleran side effect on Aug 24, 2006. Female patient, 47 years of age, weighting 121.3 lb, was diagnosed with acute leukaemia and was treated with Myleran. After drug was administered, patient experienced the following side effects: atelectasis, dyspnoea, lung cyst benign, lung infiltration, pulmonary fibrosis What is  pulmonary fibrosis. Myleran dosage: unknown. During the same period patient was treated with MELPHALAN. Patient was hospitalized.



Myleran Side Effects Report #5106555-6
Myleran side effect was reported by a Consumer or non-health professional from FRANCE on Aug 24, 2006. Female patient, 47 years of age, weighting 121.3 lb, was diagnosed with acute leukaemia and was treated with Myleran. After drug was administered, patient experienced the following side effects: atelectasis, dyspnoea, lung cyst benign, lung infiltration, obstructive airways disorder, pulmonary fibrosis What is  pulmonary fibrosis. Myleran dosage: 8MG PER DAY. During the same period patient was treated with ALKERAN, MELPHALAN. Patient was hospitalized.



Myleran Side Effects Report #5127290-4
Consumer or non-health professional from GERMANY reported Myleran side effect on Sept 29, 2006. Female patient, 55 years of age, was diagnosed with bone marrow conditioning regimen and was treated with Myleran. After drug was administered, patient experienced the following side effects: abdominal pain What is  abdominal pain, activated partial thromboplastin time prolonged, ascites, cerebral haemorrhage, complications of bone marrow transplant, diarrhoea, flatulence, haemodialysis, hepatic failure. Myleran dosage: unknown. During the same period patient was treated with ANTITHYMOCYTE IG, CYCLOSPORINE, ACYCLOVIR, LEVOFLOXACIN, CYCLOPHOSPHAMIDE, FLUCONAZOLE, PREDNISONE. Patient died.



Myleran Side Effects Report #5391222-4
Myleran side effect was reported by a Consumer or non-health professional from UNITED STATES on July 10, 2007. Female patient was diagnosed with stem cell transplant and was treated with Myleran. After drug was administered, patient experienced the following side effects: enterococcal sepsis. Myleran dosage: 1 MG/KG / SEE TEXT / ORAL. During the same period patient was treated with ETOPOSIDE, CYCLOPHOSPHAMIDE. Patient died.



Myleran Side Effects Report #5391247-9
Consumer or non-health professional from UNITED STATES reported Myleran side effect on July 10, 2007. Female patient was diagnosed with stem cell transplant and was treated with Myleran. After drug was administered, patient experienced the following side effects: venoocclusive liver disease. Myleran dosage: 1 MG/KG / SEE TEXT / ORAL. During the same period patient was treated with ETOPOSIDE, CYCLOPHOSPHAMIDE. Patient died.




Myleran Side Effects Report #5512944-8
Myleran side effect was reported by a Pharmacist from UNITED STATES on Nov 08, 2007. Female patient, 86 years of age, was diagnosed with polycythaemia vera and was treated with Myleran. After drug was administered, patient experienced the following side effects: pulmonary fibrosis What is  pulmonary fibrosis. Myleran dosage: unknown. During the same period patient was treated with LASIX, THYROID, HYDROXYUREA.



Myleran Side Effects Report #5609697-1
Consumer or non-health professional from POLAND reported Myleran side effect on Jan 22, 2008. Female patient, child 5 years of age, weighting 44.09 lb, was treated with Myleran. After drug was administered, patient experienced the following side effects: brain oedema, cardiovascular insufficiency, hepatomegaly, pulmonary oedema, respiratory failure, venoocclusive disease. Myleran dosage: unknown. During the same period patient was treated with ENDOXAN. Patient died on 10/22/2007.



Myleran Side Effects Report #5903323-X
Myleran side effect was reported by a Consumer or non-health professional from GERMANY on Sept 25, 2008. Female patient, 55 years of age, weighting 110.2 lb, was treated with Myleran. After drug was administered, patient experienced the following side effects: ageusia, aphthous stomatitis, paraesthesia, polyneuropathy. Myleran dosage: 4MG PER DAY.



Myleran Side Effects Report #6004070-9
Consumer or non-health professional from SWEDEN reported Myleran side effect on Dec 10, 2008. Male patient, 27 years of age, was diagnosed with lymphoma What is  lymphoma and was treated with Myleran. After drug was administered, patient experienced the following side effects: hearing impaired. Myleran dosage: unknown. During the same period patient was treated with FLUDARA, FRESENIUS, URSO FALK, DIFLUCAN, SANDIMMUNE, FRAGMIN, SULFAMETHOXAZOLE AND TRIMETHOPRIM DOUBLE STRENGTH, EMGESAN.



Myleran Side Effects Report #4606919-0
Myleran side effect was reported by a Consumer or non-health professional from on Feb 24, 2005. Female patient was diagnosed with bone marrow transplant What is  bone marrow transplant and was treated with Myleran. After drug was administered, patient experienced the following side effects: mucosal inflammation. Myleran dosage: 1 MG/KG/SEE TEXT/INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, ETOPOSIDE, STEM CELL TRANSPLANT. Patient died.




Myleran Side Effects Report #4607695-8
Consumer or non-health professional from reported Myleran side effect on Feb 21, 2005. Female patient, 14 years of age, was treated with Myleran. After drug was administered, patient experienced the following side effects: accidental overdose, convulsion, cytomegalovirus infection What is  cytomegalovirus infection, graft versus host disease, hyperbilirubinaemia, multi-organ failure, sepsis What is  sepsis. Myleran dosage: unknown. During the same period patient was treated with ANTITHYMOCYTE IG.



Myleran Side Effects Report #4621370-5
Myleran side effect was reported by a Consumer or non-health professional from on Mar 14, 2005. Male patient, 40 years of age, was treated with Myleran. After drug was administered, patient experienced the following side effects: anaemia haemolytic autoimmune. Myleran dosage: unknown. During the same period patient was treated with FLUDARABINE PHOSPHATE.



Myleran Side Effects Report #4626837-1
Consumer or non-health professional from reported Myleran side effect on Mar 22, 2005. Male patient, 15 years of age, was treated with Myleran. After drug was administered, patient experienced the following side effects: engraftment syndrome, febrile neutropenia, gastrointestinal toxicity. Myleran dosage: unknown. During the same period patient was treated with ALKERAN, HYCAMTIN, GRANULOCYTE COL.



Myleran Side Effects Report #4626838-3
Myleran side effect was reported by a Consumer or non-health professional from on Mar 22, 2005. Male patient, child 5 years of age, was treated with Myleran. After drug was administered, patient experienced the following side effects: febrile neutropenia, gastrointestinal toxicity, transplant failure. Myleran dosage: unknown. During the same period patient was treated with ALKERAN, GRANULOCYTE COL. Patient died.



Myleran Side Effects Report #4626839-5
Consumer or non-health professional from reported Myleran side effect on Mar 22, 2005. Male patient, child 3 years of age, was treated with Myleran. After drug was administered, patient experienced the following side effects: complications of bone marrow transplant, febrile neutropenia, gastrointestinal toxicity, sepsis What is  sepsis. Myleran dosage: unknown. During the same period patient was treated with ALKERAN, GRANULOCYTE COL. Patient died.




Myleran Side Effects Report #4626840-1
Myleran side effect was reported by a Consumer or non-health professional from on Mar 22, 2005. Male patient was treated with Myleran. After drug was administered, patient experienced the following side effects: complications of transplant surgery, febrile neutropenia, gastrointestinal toxicity, sepsis What is  sepsis. Myleran dosage: unknown. During the same period patient was treated with THIOTEPA, GRANULOCYTE COL. Patient died.



Myleran Side Effects Report #4628649-1
Consumer or non-health professional from reported Myleran side effect on Mar 21, 2005. Female patient was treated with Myleran. After drug was administered, patient experienced the following side effects: infection What is  infection. Myleran dosage: 3.2 MG/KG/SINGLE DOSE / INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE. Patient died.



Myleran Side Effects Report #4629337-8
Myleran side effect was reported by a Consumer or non-health professional from on Mar 22, 2005. Female patient, 14 years of age, was treated with Myleran. After drug was administered, patient experienced the following side effects: engraftment syndrome, febrile neutropenia, gastrointestinal toxicity. Myleran dosage: unknown. During the same period patient was treated with ALKERAN, GRANULOCYTE COL.



Myleran Side Effects Report #4629338-X
Consumer or non-health professional from reported Myleran side effect on Mar 22, 2005. Female patient was treated with Myleran. After drug was administered, patient experienced the following side effects: convulsion, febrile neutropenia, gastrointestinal toxicity, neurotoxicity, sepsis What is  sepsis. Myleran dosage: unknown. During the same period patient was treated with THIOTEPA, GRANULOCYTE COL.



Myleran Side Effects Report #4629339-1
Myleran side effect was reported by a Consumer or non-health professional from on Mar 22, 2005. Male patient was treated with Myleran. After drug was administered, patient experienced the following side effects: convulsion, febrile neutropenia, gastrointestinal toxicity, neurotoxicity. Myleran dosage: unknown. During the same period patient was treated with THIOTEPA, GRANULOCYTE COL.




Myleran Side Effects Report #4629340-8
Consumer or non-health professional from reported Myleran side effect on Mar 22, 2005. Male patient, child 4 years of age, was treated with Myleran. After drug was administered, patient experienced the following side effects: engraftment syndrome, febrile neutropenia, gastrointestinal toxicity, venoocclusive disease. Myleran dosage: unknown. During the same period patient was treated with THIOTEPA, GRANULOCYTE COL.



Myleran Side Effects Report #4629541-9
Myleran side effect was reported by a Consumer or non-health professional from on Mar 22, 2005. Male patient was treated with Myleran. After drug was administered, patient experienced the following side effects: febrile neutropenia, gastrointestinal toxicity, sepsis What is  sepsis. Myleran dosage: unknown. During the same period patient was treated with ALKERAN, THIOTEPA, GRANULOCYTE COL.



Myleran Side Effects Report #4629542-0
Consumer or non-health professional from reported Myleran side effect on Mar 22, 2005. Male patient was treated with Myleran. After drug was administered, patient experienced the following side effects: febrile neutropenia, gastrointestinal toxicity. Myleran dosage: unknown. During the same period patient was treated with ALKERAN, THIOTEPA, GRANULOCYTE COL.



Myleran Side Effects Report #4629544-4
Myleran side effect was reported by a Consumer or non-health professional from on Mar 22, 2005. Female patient, child 5 years of age, was treated with Myleran. After drug was administered, patient experienced the following side effects: engraftment syndrome, febrile neutropenia, gastrointestinal toxicity, sepsis What is  sepsis. Myleran dosage: unknown. During the same period patient was treated with ALKERAN, THIOTEPA, GRANULOCYTE COL.



Myleran Side Effects Report #4629545-6
Consumer or non-health professional from reported Myleran side effect on Mar 22, 2005. Female patient, child 9 years of age, was treated with Myleran. After drug was administered, patient experienced the following side effects: engraftment syndrome, febrile neutropenia, gastrointestinal toxicity. Myleran dosage: unknown. During the same period patient was treated with ALKERAN, HYCAMTIN, GRANULOCYTE COL.




Myleran Side Effects Report #4629546-8
Myleran side effect was reported by a Consumer or non-health professional from on Mar 22, 2005. Female patient was treated with Myleran. After drug was administered, patient experienced the following side effects: febrile neutropenia, gastrointestinal toxicity, varicella. Myleran dosage: unknown. During the same period patient was treated with ALKERAN, HYCAMTIN, GRANULOCYTE.



Myleran Side Effects Report #4629548-1
Consumer or non-health professional from reported Myleran side effect on Mar 22, 2005. Male patient, child 4 years of age, was treated with Myleran. After drug was administered, patient experienced the following side effects: febrile neutropenia, gastrointestinal toxicity. Myleran dosage: unknown. During the same period patient was treated with ALKERAN, HYCAMTIN, GRANULOCYTE COL.



Myleran Side Effects Report #4629549-3
Myleran side effect was reported by a Consumer or non-health professional from on Mar 21, 2005. Female patient was treated with Myleran. After drug was administered, patient experienced the following side effects: infection What is  infection. Myleran dosage: 1 MG/KG SEE TEXT/ ORAL. During the same period patient was treated with ETOPOSIDE, CYCLOPHOSPHAMIDE. Patient died.



Myleran Side Effects Report #4629551-1
Consumer or non-health professional from reported Myleran side effect on Mar 21, 2005. Female patient was treated with Myleran. After drug was administered, patient experienced the following side effects: venoocclusive liver disease. Myleran dosage: 1 MG/KG/ SEE TEXT / ORAL. During the same period patient was treated with ETOPOSIDE, CYCLOPHOSPHAMIDE. Patient died.



Myleran Side Effects Report #4630685-6
Myleran side effect was reported by a Consumer or non-health professional from on Mar 22, 2005. Female patient, child 6 years of age, was treated with Myleran. After drug was administered, patient experienced the following side effects: febrile neutropenia, gastrointestinal toxicity, sepsis What is  sepsis. Myleran dosage: unknown. During the same period patient was treated with ALKERAN, GRANULOCYTE.




Myleran Side Effects Report #4630688-1
Consumer or non-health professional from reported Myleran side effect on Mar 22, 2005. Female patient, 15 years of age, was treated with Myleran. After drug was administered, patient experienced the following side effects: febrile neutropenia, gastrointestinal toxicity, sepsis What is  sepsis. Myleran dosage: unknown. During the same period patient was treated with ALKERAN, GRANULOCYTE.



Myleran Side Effects Report #4630689-3
Myleran side effect was reported by a Consumer or non-health professional from on Mar 22, 2005. Male patient, child 5 years of age, was treated with Myleran. After drug was administered, patient experienced the following side effects: bone sarcoma, febrile neutropenia, gastrointestinal toxicity. Myleran dosage: unknown. During the same period patient was treated with THIOTEPA, GRANULOCYTE.



Myleran Side Effects Report #4630690-X
Consumer or non-health professional from reported Myleran side effect on Mar 22, 2005. Male patient, child 12 years of age, was treated with Myleran. After drug was administered, patient experienced the following side effects: febrile neutropenia, gastrointestinal toxicity, venoocclusive disease. Myleran dosage: unknown. During the same period patient was treated with THIOTEPA, GRANULOCYTE.



Myleran Side Effects Report #4630696-0
Myleran side effect was reported by a Consumer or non-health professional from on Mar 22, 2005. Male patient, 14 years of age, was treated with Myleran. After drug was administered, patient experienced the following side effects: febrile neutropenia, gastrointestinal toxicity, sepsis What is  sepsis. Myleran dosage: unknown. During the same period patient was treated with THIOTEPA, GRANULOCYTE.



Myleran Side Effects Report #4633874-X
Consumer or non-health professional from reported Myleran side effect on Apr 01, 2005. Male patient, 55 years of age, was treated with Myleran. After drug was administered, patient experienced the following side effects: ascites, hepatic failure. Myleran dosage: 4 MG/KG/ VARIABLE DOSE. During the same period patient was treated with FLUDARABINE PHOSPHATE, ANTITHYMOCYTE IG, GRANULOCYTE COL. Patient died.




Myleran Side Effects Report #4633878-7
Myleran side effect was reported by a Consumer or non-health professional from on Apr 01, 2005. Male patient, 38 years of age, was treated with Myleran. After drug was administered, patient experienced the following side effects: graft versus host disease. Myleran dosage: 4 MG/KG/ VARIABLE DOSE. During the same period patient was treated with FLUDARABINE PHOSPHATE, ANTITHYMOCYTE IG, GRANULOCYTE COL. Patient died.



Myleran Side Effects Report #4633883-0
Consumer or non-health professional from reported Myleran side effect on Apr 01, 2005. Male patient, 67 years of age, was treated with Myleran. After drug was administered, patient experienced the following side effects: aspergillosis, graft dysfunction, graft versus host disease. Myleran dosage: 4 MG/KG/VARIABLE DOSE/ UNK. During the same period patient was treated with FLUDARABINE PHOSPHATE, ANTIHYMOCYTE IG, GRANULOCYTE COL. Patient died.



Myleran Side Effects Report #4709621-X
Myleran side effect was reported by a Physician from INDIA on June 20, 2005. Female patient, 46 years of age, was diagnosed with chronic myeloid leukaemia and was treated with Myleran. After drug was administered, patient experienced the following side effects: bacteria blood identified, bone marrow depression, bone marrow disorder, escherichia infection, febrile neutropenia, fibrosis, gastroenteritis What is  gastroenteritis, lung infiltration. Myleran dosage: unknown. During the same period patient was treated with INTERFERON ALFA, IMATINIB MESYLATE, CYTARABINE. Patient was hospitalized. Patient died.



Myleran Side Effects Report #4749068-3
Consumer or non-health professional from AUSTRALIA reported Myleran side effect on Aug 10, 2005. Female patient, 64 years of age, was diagnosed with mantle cell lymphoma and was treated with Myleran. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, pneumonitis, pulmonary toxicity, respiratory failure. Myleran dosage: 1 MG/KG/FOUR TIMES PER DAY/ORAL. During the same period patient was treated with ALKERAN, CLONAZEPAM, RITUXIMAB, FLUCONAZOLE, ANTIBIOTICS, CORTICOSTEROID. Patient died.



Myleran Side Effects Report #4749070-1
Myleran side effect was reported by a Consumer or non-health professional from AUSTRALIA on Aug 10, 2005. Male patient, 61 years of age, was diagnosed with mantle cell lymphoma and was treated with Myleran. After drug was administered, patient experienced the following side effects: blood immunoglobulin g decreased, cough, influenza, lung infiltration, pneumonitis, pulmonary toxicity, respiratory failure, sepsis What is  sepsis, streptococcal infection What is  streptococcal infection. Myleran dosage: 1 MG/KG/FOUR TIMES PER DAY/ORAL. During the same period patient was treated with MELPHALAN, CLONAZEPAM, RITUXIMAB, FLUCONAZOLE. Patient died.



Myleran Side Effects Report #4749071-3
Consumer or non-health professional from AUSTRALIA reported Myleran side effect on Aug 10, 2005. Male patient, 58 years of age, was diagnosed with mantle cell lymphoma and was treated with Myleran. After drug was administered, patient experienced the following side effects: pneumonitis, pulmonary toxicity, pyrexia, respiratory failure. Myleran dosage: 1 MG/KG/FOUR TIMES PER DAY/ORAL. During the same period patient was treated with ALKERAN, CLONAZEPAM, RITUXIMAB, FLUCONAZOLE. Patient died.



Myleran Side Effects Report #4805329-0
Myleran side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 05, 2005. Male patient, 49 years of age, was treated with Myleran. After drug was administered, patient experienced the following side effects: ascites, encephalopathy, international normalised ratio increased, multi-organ failure, venoocclusive liver disease. Myleran dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient died.



Myleran Side Effects Report #4805356-3
Consumer or non-health professional from UNITED KINGDOM reported Myleran side effect on Oct 05, 2005. Female patient, 34 years of age, was treated with Myleran. After drug was administered, patient experienced the following side effects: encephalopathy, hepatic rupture, peritoneal haemorrhage, venoocclusive liver disease. Myleran dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, THIACETAZONE. Patient died.



Myleran Side Effects Report #4805358-7
Myleran side effect was reported by a Consumer or non-health professional from UNITED KINGDOM on Oct 05, 2005. Female patient, 36 years of age, was treated with Myleran. After drug was administered, patient experienced the following side effects: haemodialysis, international normalised ratio increased, renal impairment, respiratory failure, sepsis What is  sepsis, venoocclusive liver disease. Myleran dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE. Patient died.



Myleran Side Effects Report #5034670-4
Consumer or non-health professional from GERMANY reported Myleran side effect on June 08, 2006. Female patient was diagnosed with stem cell transplant and was treated with Myleran. After drug was administered, patient experienced the following side effects: aplasia, graft versus host disease in skin, neutrophil count abnormal, platelet count decreased, sepsis What is  sepsis. Myleran dosage: 3.3 MG/KG/INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOSPORINE.




Myleran Side Effects Report #5034671-6
Myleran side effect was reported by a Consumer or non-health professional from GERMANY on June 08, 2006. Female patient was diagnosed with stem cell transplant and was treated with Myleran. After drug was administered, patient experienced the following side effects: aplasia, graft versus host disease in skin, neutrophil count abnormal, platelet count decreased. Myleran dosage: 3.3 MG/KG /INTRAVENOUS. During the same period patient was treated with FLUDARABINE PHOSPHATE, CYCLOSPORINE.



Showing 1-50 of 51 Next >


Go to the top of the page

side effects on twitter
Follow Us on Twitter

Did You Have a Myleran Side Effect?
Yes, Severe
Yes, Moderate
Yes, Minor
No




a service provided by JustAnswer

How Effective is Myleran for You?
Exceeded Expectations
Effective
Somewhat Effective
Not Effective



The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. PatientsVille.com does not provide medical advice, diagnosis or treatment. The information contained on PatientsVille.com site has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of adverse drug reactions or for establishing or changing of patient treatments.


Thank you for visiting Patientsville.com. We hope you found our information about Myleran Side Effects helpful.